| 规格: | 98% |
| 分子量: | 542.64 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
Background:
BIIB091 is a highly selective, reversible BTK inhibitor for treating autoimmune diseases.
[1]. Hopkins BT, et al. Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis. J Med Chem. 2021 Nov 4.
m.cnreagent.com